• English (English)
Locust Walk
  • About Us
    • Engaging with Us
    • Industry Segments
    • Our Team
      • Leadership
      • Advisory Board
  • Our Capabilities
    • Deal Process
    • Strategy Consulting
    • Capital Markets
    • Strategic Transactions
  • Our Transactions
  • Insights
    • Thought Leadership
    • Webinars & Panels
    • News
  • Careers
    • Our Careers
    • Our Core Values
    • Our Culture
    • Our Community Support
  • Contact Us
Select Page

InterMune Divests Actimmune to Vidara Therapeutics

May 10, 2012

The Locust Walk team is proud to share with you today’s news of our client, InterMune’s, divestiture of Actimmune® (interferon gamma-1b) to Vidara Therapeutics.


 

Related Posts

  • Biotalk Episode 2: Bradley Campbell, Amicus Therapeutics
  • Hello world!
  • Cortendo adds two late‐stage assets and announces $33M financing

Categories

  • News
  • Events
  • Publications

Archive

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008

BOSTON

200 Clarendon Street
51st Floor
Boston, MA 02116

info@locustwalk.com

Privacy Policy

Terms of Use

NEW YORK

420 Lexington Avenue
Suite 2515
New York, NY 10170

LONDON

20 Eastbourne Terrace
London W2 6LG, UK

TOKYO

PMO Nihonbashi Muromachi 3F
1-13-7 Nihonbashi Muromachi
Chuo-ku, Japan 103-0022

SAN FRANCISCO

580 California Street
12th & 16th Floors
San Francisco, CA 94104

  • LinkedIn
  • Twitter
  • YouTube

Designed by Gill Fishman Associates